TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
This Week,” a series that highlights noteworthy news related to women and U.S. foreign policy. This week’s post covers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results